A jury on Friday found that Abbott Laboratories’ specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay $495 million in compensatory and punitive damages.

The verdict in St. Louis, Missouri state court comes in the first trial against the company out of hundreds of similar claims over the formula pending in courts around the country, which Reuters viewed via Courtroom View Network.

The jury awarded $95 million in compensatory damages and $400 million in punitive damages.

Before the jury was sent to consider punitive damages, Abbott attorney James Hurst said that the verdict risks sending the wrong message and limiting doctors’ options for feeding preterm infants who cannot breastfeed.